FASEB J.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Esmon, C. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Esmon, C. T.

The FASEB Journal, Vol 9, 946-955, Copyright © 1995 by The Federation of American Societies for Experimental Biology

REVIEWS

Thrombomodulin as a model of molecular mechanisms that modulate protease specificity and function at the vessel surface

CT Esmon
Oklahoma Medical Research Foundation, Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, USA.

The protein C anticoagulant system generates an "on demand" physiologic anticoagulant response. The pathway is initiated when thrombin binds to the endothelial cell thrombin binding protein, thrombomodulin. The complex exhibits dramatically altered macromolecular specificity. It rapidly cleaves the protein C zymogen to form the anticoagulant, activated protein C. Complex formation between thrombin and thrombomodulin also prevents thrombin, the enzyme responsible for clot formation and a potent platelet activator, from being able to clot fibrinogen or to activate platelets. Structural, kinetic, and competition studies suggest that thrombomodulin blocks these clotting reactions by masking the binding sites for fibrinogen and the platelet thrombin receptor. Stimulation of protein C activation appears to occur through conformational changes in the extended binding pocket of thrombin. This prevents repulsive interactions with protein C that exist when the free enzyme attempts to dock with this substrate. In addition to protein-protein interactions, thrombomodulin has a covalently associated chondroitin sulfate moiety. Chondroitin sulfate binds to a basic surface on thrombin that is also involved in heparin interaction. The chondroitin sulfate enhances the affinity of thrombin for thrombomodulin approximately 10- to 20-fold, making thrombomodulin a more potent inhibitor of coagulation, altering thrombin's conformation and specificity, and accelerating thrombin inhibition by the serpin, antithrombin. These properties make thrombomodulin a molecular switch ideally suited to trigger an anticoagulant response when too much thrombin is generated. The importance of the system is documented by the clinical observation that patients deficient in protein C often die of massive thrombotic complications that can be reversed or prevented by infusion of protein C.


This article has been cited by other articles:


Home page
 Proc. Natl. Acad. Sci. USAHome page
P. S. Gandhi, Z. Chen, F. S. Mathews, and E. Di Cera
Structural identification of the pathway of long-range communication in an allosteric enzyme
PNAS, February 12, 2008; 105(6): 1832 - 1837.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
N. Takeda, K. Maemura, S. Horie, K. Oishi, Y. Imai, T. Harada, T. Saito, T. Shiga, E. Amiya, I. Manabe, et al.
Thrombomodulin Is a Clock-controlled Gene in Vascular Endothelial Cells
J. Biol. Chem., November 9, 2007; 282(45): 32561 - 32567.
[Abstract] [Full Text] [PDF]

Home page
 J. Dent. Res.Home page
Z.M. Yan, Z.P. Fan, J. Du, H. Hua, Y.Y. Xu, and S.L. Wang
A Novel Mutation in ALK-1 Causes Hereditary Hemorrhagic Telangiectasia Type 2.
J. Dent. Res., August 1, 2006; 85(8): 705 - 710.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C. Feistritzer, R. A. Schuepbach, L. O. Mosnier, L. A. Bush, E. Di Cera, J. H. Griffin, and M. Riewald
Protective Signaling by Activated Protein C Is Mechanistically Linked to Protein C Activation on Endothelial Cells
J. Biol. Chem., July 21, 2006; 281(29): 20077 - 20084.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
R. J. Dekker, R. A. Boon, M. G. Rondaij, A. Kragt, O. L. Volger, Y. W. Elderkamp, J. C. M. Meijers, J. Voorberg, H. Pannekoek, and A. J. G. Horrevoets
KLF2 provokes a gene expression pattern that establishes functional quiescent differentiation of the endothelium
Blood, June 1, 2006; 107(11): 4354 - 4363.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
Y. Banz, O. M. Hess, S. C. Robson, D. Mettler, P. Meier, A. Haeberli, E. Csizmadia, E. Y. Korchagina, N. V. Bovin, and R. Rieben
Locally targeted cytoprotection with dextran sulfate attenuates experimental porcine myocardial ischaemia/reperfusion injury
Eur. Heart J., November 1, 2005; 26(21): 2334 - 2343.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Riewald and W. Ruf
Protease-activated Receptor-1 Signaling by Activated Protein C in Cytokine-perturbed Endothelial Cells Is Distinct from Thrombin Signaling
J. Biol. Chem., May 20, 2005; 280(20): 19808 - 19814.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
C. Feistritzer and M. Riewald
Endothelial barrier protection by activated protein C through PAR1-dependent sphingosine 1-phosphate receptor-1 crossactivation
Blood, April 15, 2005; 105(8): 3178 - 3184.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
M. Uchiba, K. Okajima, Y. Oike, Y. Ito, K. Fukudome, H. Isobe, and T. Suda
Activated Protein C Induces Endothelial Cell Proliferation by Mitogen-Activated Protein Kinase Activation In Vitro and Angiogenesis In Vivo
Circ. Res., July 9, 2004; 95(1): 34 - 41.
[Abstract] [Full Text] [PDF]

Home page
 J BiochemHome page
H. Yonemura, T. Imamura, K. Soejima, Y. Nakahara, W. Morikawa, Y. Ushio, Y. Kamachi, H. Nakatake, K. Sugawara, T. Nakagaki, et al.
Preparation of Recombinant {alpha}-Thrombin: High-Level Expression of Recombinant Human Prethrombin-2 and Its Activation by Recombinant Ecarin
J. Biochem., May 1, 2004; 135(5): 577 - 582.
[Abstract] [Full Text] [PDF]

Home page
 Protein Sci.Home page
A. Baerga-Ortiz, S. Bergqvist, J. G. Mandell, and E. A. Komives
Two different proteins that compete for binding to thrombin have opposite kinetic and thermodynamic profiles
Protein Sci., January 1, 2004; 13(1): 166 - 176.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
H.-C. Huang, G.-Y. Shi, S.-J. Jiang, C.-S. Shi, C.-M. Wu, H.-Y. Yang, and H.-L. Wu
Thrombomodulin-mediated Cell Adhesion: INVOLVEMENT OF ITS LECTIN-LIKE DOMAIN
J. Biol. Chem., November 21, 2003; 278(47): 46750 - 46759.
[Abstract] [Full Text] [PDF]

Home page
 Innate ImmunityHome page
M. Riewald, R. J. Petrovan, A. Donner, and W. Ruf
Activated protein C signals through the thrombin receptor PAR1 in endothelial cells
Innate Immunity, October 1, 2003; 9(5): 317 - 321.
[Abstract] [PDF]

Home page
 Cancer Res.Home page
R. G. Bagley, J. Walter-Yohrling, X. Cao, W. Weber, B. Simons, B. P. Cook, S. D. Chartrand, C. Wang, S. L. Madden, and B. A. Teicher
Endothelial Precursor Cells As a Model of Tumor Endothelium: Characterization and Comparison with Mature Endothelial Cells
Cancer Res., September 15, 2003; 63(18): 5866 - 5873.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
H. Koike, D. Okuda, and T. Morita
Mutations in Autolytic Loop-2 and at Asp554 of Human Prothrombin That Enhance Protein C Activation by Meizothrombin
J. Biol. Chem., April 18, 2003; 278(17): 15015 - 15022.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
K. K. Wu, N. Aleksic, C. M. Ballantyne, C. Ahn, H. Juneja, and E. Boerwinkle
Interaction Between Soluble Thrombomodulin and Intercellular Adhesion Molecule-1 in Predicting Risk of Coronary Heart Disease
Circulation, April 8, 2003; 107(13): 1729 - 1732.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
S. R. Lentz
Thrombosis of Vein Grafts: Wall Tension Restrains Thrombomodulin Expression
Circ. Res., January 10, 2003; 92(1): 12 - 13.
[Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
R.-B. Yang, C. K. D. Ng, S. M. Wasserman, S. D. Colman, S. Shenoy, F. Mehraban, L. G. Komuves, J. E. Tomlinson, and J. N. Topper
Identification of a Novel Family of Cell-surface Proteins Expressed in Human Vascular Endothelium
J. Biol. Chem., November 22, 2002; 277(48): 46364 - 46373.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
S. R. Lentz, F. J. Miller Jr, D. J. Piegors, R. A. Erger, J. A. Fernandez, J. H. Griffin, and D. D. Heistad
Anticoagulant Responses to Thrombin Are Enhanced During Regression of Atherosclerosis in Monkeys
Circulation, August 13, 2002; 106(7): 842 - 846.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
M. Riewald, R. J. Petrovan, A. Donner, B. M. Mueller, and W. Ruf
Activation of Endothelial Cell Protease Activated Receptor 1 by the Protein C Pathway
Science, June 7, 2002; 296(5574): 1880 - 1882.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
G. Kunz, A.-K. Ohlin, A. Adami, B. Zoller, P. Svensson, and D. A. Lane
Naturally occurring mutations in the thrombomodulin gene leading to impaired expression and function
Blood, May 15, 2002; 99(10): 3646 - 3653.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
M. Christofidou-Solomidou, S. Kennel, A. Scherpereel, R. Wiewrodt, C. C. Solomides, G. G. Pietra, J.-C. Murciano, S. A. Shah, H. Ischiropoulos, S. M. Albelda, et al.
Vascular Immunotargeting of Glucose Oxidase to the Endothelial Antigens Induces Distinct Forms of Oxidant Acute Lung Injury : Targeting to Thrombomodulin, But Not to PECAM-1, Causes Pulmonary Thrombosis and Neutrophil Transmigration
Am. J. Pathol., March 1, 2002; 160(3): 1155 - 1169.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
I. M. Verhamme, S. T. Olson, D. M. Tollefsen, and P. E. Bock
Binding of Exosite Ligands to Human Thrombin. RE-EVALUATION OF ALLOSTERIC LINKAGE BETWEEN THROMBIN EXOSITES I AND II
J. Biol. Chem., February 22, 2002; 277(9): 6788 - 6798.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
M. Blank, Y. Shoenfeld, S. Tavor, S. Praprotnik, M. C. Boffa, B. Weksler, M. J. Walenga, J. Amiral, and A. Eldor
Anti-platelet factor 4/heparin antibodies from patients with heparin-induced thrombocytopenia provoke direct activation of microvascular endothelial cells
Int. Immunol., February 1, 2002; 14(2): 121 - 129.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
R. Wiewrodt, A. P. Thomas, L. Cipelletti, M. Christofidou-Solomidou, D. A. Weitz, S. I. Feinstein, D. Schaffer, S. M. Albelda, M. Koval, and V. R. Muzykantov
Size-dependent intracellular immunotargeting of therapeutic cargoes into endothelial cells
Blood, February 1, 2002; 99(3): 912 - 922.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
R. Opavsky, P. Haviernik, D. Jurkovicova, M. T. Garin, N. G. Copeland, D. J. Gilbert, N. A. Jenkins, J. Bies, S. Garfield, S. Pastorekova, et al.
Molecular Characterization of the Mouse Tem1/endosialin Gene Regulated by Cell Density in Vitro and Expressed in Normal Tissues in Vivo
J. Biol. Chem., October 12, 2001; 276(42): 38795 - 38807.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
S. M. Danilov, V. D. Gavrilyuk, F. E. Franke, K. Pauls, D. W. Harshaw, T. D. McDonald, D. J. Miletich, and V. R. Muzykantov
Lung uptake of antibodies to endothelial antigens: key determinants of vascular immunotargeting
Am J Physiol Lung Cell Mol Physiol, June 1, 2001; 280(6): L1335 - L1347.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
K. K. Wu, N. Aleksic, C. Ahn, E. Boerwinkle, A. R. Folsom, and H. Juneja
Thrombomodulin Ala455Val Polymorphism and Risk of Coronary Heart Disease
Circulation, March 13, 2001; 103(10): 1386 - 1389.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
S. Praprotnik, M. Blank, Y. Levy, S. Tavor, M.-C. Boffa, B. Weksler, A. Eldor, and Y. Shoenfeld
Anti-endothelial cell antibodies from patients with thrombotic thrombocytopenic purpura specifically activate small vessel endothelial cells
Int. Immunol., February 1, 2001; 13(2): 203 - 210.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
H. Larsson, T. Sjöblom, J. Dixelius, A. Östman, K. Ylinenjärvi, I. Björk, and L. Claesson-Welsh
Antiangiogenic Effects of Latent Antithrombin through Perturbed Cell-Matrix Interactions and Apoptosis of Endothelial Cells
Cancer Res., December 1, 2000; 60(23): 6723 - 6729.
[Abstract] [Full Text]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
L. Bajzar
Thrombin Activatable Fibrinolysis Inhibitor and an Antifibrinolytic Pathway
Arterioscler. Thromb. Vasc. Biol., December 1, 2000; 20(12): 2511 - 2518.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Nguyen, J. Arkell, and C. J. Jackson
Activated Protein C Directly Activates Human Endothelial Gelatinase A
J. Biol. Chem., March 24, 2000; 275(13): 9095 - 9098.
[Abstract] [Full Text] [PDF]

Home page
 LupusHome page
J D Pearson
Normal endothelial cell function
Lupus, March 1, 2000; 9(3): 183 - 188.
[Abstract] [PDF]

Home page
 BloodHome page
G. Kunz, H. A. Ireland, P. J. Stubbs, M. Kahan, G. C. Coulton, and D. A. Lane
Identification and characterization of a thrombomodulin gene mutation coding for an elongated protein with reduced expression in a kindred with myocardial infarction
Blood, January 15, 2000; 95(2): 569 - 576.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
J. J. Peterson, H. B. Rayburn, D. J. Lager, T. J. Raife, G. P. Kealey, R. D. Rosenberg, and S. R. Lentz
Expression of Thrombomodulin and Consequences of Thrombomodulin Deficiency during Healing of Cutaneous Wounds
Am. J. Pathol., November 1, 1999; 155(5): 1569 - 1575.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
S. R. Lentz, J. A. Fernandez, J. H. Griffin, D. J. Piegors, R. A. Erger, M. R. Malinow, and D. D. Heistad
Impaired Anticoagulant Response to Infusion of Thrombin in Atherosclerotic Monkeys Associated With Acquired Defects in the Protein C System
Arterioscler. Thromb. Vasc. Biol., July 1, 1999; 19(7): 1744 - 1750.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
E. M. Conway, S. Pollefeyt, J. Cornelissen, I. DeBaere, M. Steiner-Mosonyi, J. I. Weitz, H. Weiler-Guettler, P. Carmeliet, and D. Collen
Structure-Function Analyses of Thrombomodulin by Gene-Targeting in Mice: The Cytoplasmic Domain Is Not Required for Normal Fetal Development
Blood, May 15, 1999; 93(10): 3442 - 3450.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
D. L. Becker, J. C. Fredenburgh, A. R. Stafford, and J. I. Weitz
Exosites 1 and 2 Are Essential for Protection of Fibrin-bound Thrombin from Heparin-catalyzed Inhibition by Antithrombin and Heparin Cofactor II
J. Biol. Chem., March 5, 1999; 274(10): 6226 - 6233.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
M. Gosling, J. Golledge, R. J. Turner, and J. T. Powell
Arterial Flow Conditions Downregulate Thrombomodulin on Saphenous Vein Endothelium
Circulation, March 2, 1999; 99(8): 1047 - 1053.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
H. Wakabayashi, S. Natsuka, T. Mega, N. Otsuki, M. Isaji, M. Naotsuka, S. Koyama, T. Kanamori, K. Sakai, and S. Hase
Novel Proteoglycan Linkage Tetrasaccharides of Human Urinary Soluble Thrombomodulin, SO4-3GlcAbeta 1-3Galbeta 1-3(ąSiaalpha 2-6)Galbeta 1-4Xyl
J. Biol. Chem., February 26, 1999; 274(9): 5436 - 5442.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
X. He and A. R. Rezaie
Identification and Characterization of the Sodium-binding Site of Activated Protein C
J. Biol. Chem., February 19, 1999; 274(8): 4970 - 4976.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
K. Kokame, X. Zheng, and J. E. Sadler
Activation of Thrombin-activable Fibrinolysis Inhibitor Requires Epidermal Growth Factor-like Domain 3 of Thrombomodulin and Is Inhibited Competitively by Protein C
J. Biol. Chem., May 15, 1998; 273(20): 12135 - 12139.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. B. Boffa, W. Wang, L. Bajzar, and M. E. Nesheim
Plasma and Recombinant Thrombin-activable Fibrinolysis Inhibitor (TAFI) and Activated TAFI Compared with Respect to Glycosylation, Thrombin/Thrombomodulin-dependent Activation, Thermal Stability, and Enzymatic Properties
J. Biol. Chem., January 23, 1998; 273(4): 2127 - 2135.
[Abstract] [Full Text] [PDF]

Home page
 LupusHome page
I. Maruyama
Review : Biology of endothelium
Lupus, January 1, 1998; 7(2_suppl): S41 - S43.
[Abstract] [PDF]

Home page
 LupusHome page
M-C. Boffa and M. Karmochkine
Review : Thrombomodulin: an overview and potential implications in vascular disorders
Lupus, January 1, 1998; 7(2_suppl): S120 - S125.
[Abstract] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
M. F. Hockin, M. Kalafatis, M. Shatos, and K. G. Mann
Protein C Activation and Factor Va Inactivation on Human Umbilical Vein Endothelial Cells
Arterioscler. Thromb. Vasc. Biol., November 1, 1997; 17(11): 2765 - 2775.
[Abstract] [Full Text]

Home page
 BloodHome page
C. van `t Veer, N. J. Golden, M. Kalafatis, P. Simioni, R. M. Bertina, and K. G. Mann
An In Vitro Analysis of the Combination of Hemophilia A and Factor VLEIDEN
Blood, October 15, 1997; 90(8): 3067 - 3072.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. C. Fredenburgh, A. R. Stafford, and J. I. Weitz
Evidence for Allosteric Linkage between Exosites 1 and 2 of Thrombin
J. Biol. Chem., October 10, 1997; 272(41): 25493 - 25499.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
G. Vassalli and D. A Dichek
Gene therapy for arterial thrombosis
Cardiovasc Res, September 1, 1997; 35(3): 459 - 469.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C. van `t Veer, M. Kalafatis, R. M. Bertina, P. Simioni, and K. G. Mann
Increased Tissue Factor-initiated Prothrombin Activation as a Result of the Arg506 right-arrow Gln Mutation in Factor VLEIDEN
J. Biol. Chem., August 15, 1997; 272(33): 20721 - 20729.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
C. Garlanda and E. Dejana
Heterogeneity of Endothelial Cells : Specific Markers
Arterioscler. Thromb. Vasc. Biol., July 1, 1997; 17(7): 1193 - 1202.
[Abstract] [Full Text]

Home page
 BloodHome page
T. Bombeli, A. Karsan, J. F. Tait, and J. M. Harlan
Apoptotic Vascular Endothelial Cells Become Procoagulant
Blood, April 1, 1997; 89(7): 2429 - 2442.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C. van `t Veer, N. J. Golden, M. Kalafatis, and K. G. Mann
Inhibitory Mechanism of the Protein C Pathway on Tissue Factor-induced Thrombin Generation. SYNERGISTIC EFFECT IN COMBINATION WITH TISSUE FACTOR PATHWAY INHIBITOR
J. Biol. Chem., March 21, 1997; 272(12): 7983 - 7994.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
Y. Cadroy, A. Diquelou, D. Dupouy, J.P. Bossavy, K.S. Sakariassen, P. Sie, and B. Boneu
The Thrombomodulin/Protein C/Protein S Anticoagulant Pathway Modulates the Thrombogenic Properties of the Normal Resting and Stimulated Endothelium
Arterioscler. Thromb. Vasc. Biol., March 1, 1997; 17(3): 520 - 527.
[Abstract] [Full Text]

Home page
 BloodHome page
E. M. Conway, S. Pollefeyt, D. Collen, and M. Steiner-Mosonyi
The Amino Terminal Lectin-Like Domain of Thrombomodulin Is Required for Constitutive Endocytosis
Blood, January 15, 1997; 89(2): 652 - 661.
[Abstract] [Full Text] [PDF]

Home page
 CLIN APPL THROMB HEMOSTHome page
B. Zoller, A. Hillarp, and B. Dahlback
State-of-the-Art Review: Activated Protein C Resistance: Clinical Implications
Clinical and Applied Thrombosis/Hemostasis, January 1, 1997; 3(1): 25 - 32.
[Abstract] [PDF]

Home page
 J. Biol. Chem.Home page
J. W. Weisel, C. Nagaswami, T. A. Young, and D. R. Light
The Shape of Thrombomodulin and Interactions with Thrombin as Determined by Electron Microscopy
J. Biol. Chem., December 6, 1996; 271(49): 31485 - 31490.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
N. D. Tran, V. L.Y. Wong, S. S. Schreiber, J. V. Bready, M. Fisher, and K. Peters
Regulation of Brain Capillary Endothelial Thrombomodulin mRNA Expression
Stroke, December 1, 1996; 27(12): 2304 - 2311.
[Abstract] [Full Text]

Home page
 ScienceHome page
D. T. Berg, M. R. Wiley, and B. W. Grinnell
Enhanced Protein C Activation and Inhibition of Fibrinogen Cleavage by a Thrombin Modulator
Science, September 6, 1996; 273(5280): 1389 - 1391.
[Abstract]

Home page
 J. Biol. Chem.Home page
K. Fukudome, S. Kurosawa, D. J. Stearns-Kurosawa, X. He, A. R. Rezaie, and C. T. Esmon
The Endothelial Cell Protein C Receptor. CELL SURFACE EXPRESSION AND DIRECT LIGAND BINDING BY THE SOLUBLE RECEPTOR
J. Biol. Chem., July 19, 1996; 271(29): 17491 - 17498.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
L. Bajzar, J. Morser, and M. Nesheim
TAFI, or Plasma Procarboxypeptidase B, Couples the Coagulation and Fibrinolytic Cascades through the Thrombin-Thrombomodulin Complex
J. Biol. Chem., July 12, 1996; 271(28): 16603 - 16608.
[Abstract] [Full Text] [PDF]